CELL AND GENE THERAPY ANALYTICS
A Straightforward Path Toward Regulatory Compliance & Data Integrity With Your Microbial Testing Systems
In this webinar, we will share a variety of strategies for implementing and validating microbial identification systems in the cGMP environment, possible difficulties along the way, and a comprehensive solution that addresses these challenges.
Digital Solutions For Accelerated Innovation
In this webinar, hear how Applied Biosystems AccuSEQ software serves as an advanced digital tool that can help streamline bioanalytical processes and accelerate the delivery of life-changing therapies.
Maximize Quality Assurance Through Rapid Sterility Testing
This webinar explores mitigating the risk of product loss, and production delays, as well as the critical role rapid sterility testing plays in ensuring the quality and safety of cell therapy products.
Innovative Contamination Control: Enabling Integrity And Efficiency
An integrated approach can enhance contamination control, boost process efficiency, and ensure the production of high-quality cell therapy products.
Validation Of A qPCR Assay For Host Cell DNA Quantitation
Here, we share the development and validation of a new, highly sensitive and accurate integrated solution for detection and quantitation of host cell DNA to help meet regulatory requirements.
Inside Bioprocessing: Multi-Omics
Dive into multi-omics analysis with Paul Gulde, Chengjian Tu, and Femi Egbebi. In biopharmaceutical production, meeting the unique nutrient requirements of the cells is central to achieving optimal results.
Successful Microbial Testing And Identification
In this presentation, one of our industry-leading customers discusses how they've successfully implemented the Applied Biosystems MicroSEQ Microbial Identification System in their laboratory testing.
Rapid Process Development And Technical Support For AAV Scaleup
Accelerate your AAV production journey. Learn how rapid process development and expert support can streamline your path from vial to purified bulk, ensuring scalable and efficient manufacturing.
Analytical Approaches For Quantifying Residual Host Cell DNA
In this webinar, we’ll discuss the challenges, risks and considerations involved in developing and using in-house residual testing solutions, and the benefits of using commercial kits for residual DNA testing.
Manufacturing Hurdles With Viral Vectors
With a wide range of viral vector-based drugs already approved, viral vectors are expected to remain the primary delivery mechanism for the foreseeable future. However, as the demand for viral vectors increases, addressing the challenges related to their manufacture and s...
Market Demand For AAV Vectors
Here, Dave Maheu, VP, Head of Process & Analytical Development at Candel Therapeutics and Curran Simpson, Chief Operating Officer at REGENXBIO detail the key factors driving the adeno associated virus manufacturing market.
Scaling Viral Vectors
Industry experts cover the high operational costs associated with viral vectors, along with the challenge presented by their shot shelf life and scalability.
Regulatory Compliance And Viral Vectors
Hear from experts who detail the specific regulatory challenges for advanced therapies, as well as how the regulatory requirements differ in early research and development in academia and in industrial vector production.
Interview With Nico Chow And Sandi True, Field Applications Specialists
Hear Nico Chow and Sandi True, Field Applications Specialists, discuss working with customers to help them evaluate and implement Residual DNA Quantitation, Mycoplasma Detection, and Microbial Identification Assays.
Advancing Vaccine Development With Novel Chromatography Solutions & Quality Testing
Learn more on novel chromatography solutions that can help improve the downstream processes of different vaccine types such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).
An All-In-One Solution For Residual DNA Quantitation
Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.
Cell And Gene Therapy Innovations
This interview with a pharmaceutical analytics expert discusses key insights into advances in cell and gene therapy and the strategies used to support customers in improving their therapeutic development.
BPI Interviews Purification And Pharma Analytics Leader
Jean Luo, VP of Purification and Pharma Analytics, discusses innovations in bioprocessing, including the development of dPCR assays, lentiviral titer systems, chromatography resins, and supply chain.
Leveraging dPCR r Techniques To Quantitate Lentivirus Particles
Discover how digital PCR can streamline lentiviral vector characterization to reduce variability and improve analytical sensitivity. Learn how this approach can help you comply with regulatory guidance.
Leveraging Rapid Sterility Testing To Advance Cell Therapy Production
Explore the crucial role of rapid sterility testing in cell therapy manufacturing. This presentation delves into the benefits of swift, accurate detection for product quality and patient safety.
Analytical Solutions To Help Accelerate Bioprocessing Success
Unlock the power of data-driven bioprocessing. Discover how advanced analytics can optimize your cell culture process, improve performance, and accelerate success.
Quality Control Assays
Two company leaders detail not only the vectors their respective companies use and why but also the quality control assays performed on viral vectors.
Multi-Omics And Bioinformatics In Cell Culture Media Design
Learn about the impact of a multi-omics analysis, utilizing proteomics and metabolomics, in the development and optimization of media with the goal of improving titer, and making development and manufacturing more efficient.
Introducing The Applied Biosystems Resdnaseq Quantitative DNA System
Thermo Fisher Scientific's portfolio of resDNASEQ solutions is here to meet your specific needs enabling you to test for residual host cell DNA and release your biotherapeutics with confidence in safety and confidence in product quality.
Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration
Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.
A Straightforward Path Toward Regulatory Compliance, Data Integrity, And Computer Systems Validation
Learn practical strategies for validating microbial identification systems in cGMP. Understand regulatory guidance and master a complete Computer Systems Validation plan for full compliance.
Multi-Omics In Cell Culture Media Design
Discussing the evolution of medium design for cell culture bioprocessing, and the role that multi-omics and bioinformatics can play in improved medium development.
Interview With Pharma Analytics Field Application Specialist - Sandi True
Hear Sandi True, a Field Applications Specialist discuss helping customers navigate challenges often encountered when evaluating and implementing Residual DNA Quantitation, Mycoplasma Detection, and Microbial Identification Assays.
Innovations In Mycoplasma And Sterility Testing For Biopharma
In this webinar, our expert speakers will discuss the types of analytical testing that can be effectively employed in the early stages of therapeutic development and subsequently scaled to meet production challenges.
Overcoming Capacity Constraints
How can CGT biotechs overcome issues such as building an in house facility and ultimately get their therapies to patients.